USPH - Demand boost merits buy rating for U.S. Physical Therapy - Jefferies

An increase in physical therapy services stemming from an increase in sports activities and return to workplaces as COVID-19 eases make shares of U.S. Physical Therapy (USPH) a buy, according to Jefferies.Analyst Stephanie Wissink has a price target of $135, implying upside of 20% from the stock's most recent close.While volume was lower in 2020 due to less workforce activity, she says volume has returned to pre-COVID levels and is even accelerating now.Wissink sees potential sales expansion and ability to delivery better profitability compared to previous periods.U.S. Physical Therapy shares are up 4.6% to $117.62 in afternoon trading.

For further details see:

Demand boost merits buy rating for U.S. Physical Therapy - Jefferies